Neurosurgery Market Report 2024: Industry Data, Innovations & more

Emerging neurosurgery companies are working on solutions to overcome high costs, high-skilled labor shortages, and the need for better training and analysis capabilities. This neurosurgery report explores key market data and the areas of innovation impacting healthcare institutions worldwide.

The 2024 neurosurgery market report analyzes the current landscape and future trends in the neurosurgical field. It explores advancements in surgical techniques, medical devices, and emerging technologies such as robotics, and the integration of AI in surgical planning and execution. The report examines market dynamics, including investment patterns and firmographic data in the neurosurgery sector

This neurosurgery report serves as a reference for stakeholders within the industry, investors, policymakers, and economic analysts, providing a snapshot of the industry’s health to map its trajectory for innovation and growth in the coming years.

StartUs Insights Neurosurgery Market Report 2024

Neurosurgery-Industry-Report-HeatMap-StartUs-Insights-noresize

Executive Summary: Neurosurgery Report 2024

This report is created using data obtained from the Big Data and AI-powered StartUs Insights Discovery Platform, covering more than 4.7 million global companies, as well as 20K+ technologies and emerging trends. We also analyzed a sample of 200+ neurosurgery startups developing innovative solutions to present five examples from emerging neurosurgery industry trends.

  • Industry Growth Overview: The neurosurgery industry experiences an annual growth rate of approximately -6.16%. It involves over 200 startups and more than 3000 active companies.
  • Manpower & Employment Growth: The global neurosurgery workforce comprises over 850000 professionals, with a growth of around 35000 new employees last year.
  • Patents & Grants: The industry features more than 4500 patents and over 300 grants, underscoring strong research and development efforts.
  • Global Footprint: Key country hubs include the USA, India, Japan, Germany, and Brazil. Prominent city hubs are Sialkot, Bangalore, New Delhi, Chennai, and Hyderabad.
  • Investment Landscape: Investment in the sector averages USD 18.8 million per funding round, with participation from over 200 investors and more than 650 funding rounds closed, supporting over 200 companies.
  • Top Investors: GIC, Zimmer Biomet, the Centers for Disease Control and Prevention, and more investors have collectively made investments exceeding USD 350 million.
  • Startup Ecosystem: Highlight includes five innovative startups such as Neurochase (CED Drug Delivery System), NeuroMind (Clinical Decision Support Tools), QAS.AI (AI-based Neurovascular Treatments), SurgeonsLab (Surgical Simulations), and PreOperative Performance (Diffusion-weighted MRI Optimization).
  • Recommendations for Stakeholders: Investors should prioritize investments in technologies like robotic-assisted surgery and advanced imaging for precision and efficiency. Entrepreneurs should focus on innovative solutions that address unmet clinical needs, leveraging AI and machine learning for diagnostic and treatment advancements.

Explore the Data-driven Neurosurgery Outlook for 2024

The Neurosurgery Report 2024 uses data from the Discovery Platform and encapsulates the key metrics that underline the sector’s dynamic growth and innovation. Our database covers 200+ startups and has over 3000 companies working in this field. The current annual growth rate stands at -6.16%, indicating market challenges. The industry features more than 4500 patents, demonstrating research and development efforts. In addition, over 300 grants are supporting ongoing advancements in neurosurgery.

The global workforce comprises over 850000 professionals, with last year’s employee growth exceeding 35000 individuals. The key country hubs include the USA, India, Japan, Germany, and Brazil. While the prominent city hubs, such as Sialkot, Bangalore, New Delhi, Chennai, and Hyderabad, reflect concentrated areas of activity. The heatmap provides a comprehensive view of the distribution and dynamics within the neurosurgery market.

What data is used to create this neurosurgery report?

Based on the data provided by our Discovery Platform, we observe that the neurosurgery industry ranks among the top 5% in the following categories relative to all 20K topics in our database. These categories provide a comprehensive overview of the industry’s key metrics and inform the short-term future direction of the industry.

  • News Coverage & Publications: The industry received news coverage and published over 1300 articles in the last year.
  • Funding Rounds: More than 650 funding rounds demonstrate robust financial support and investment.
  • Manpower: With over 850000 employees worldwide, the industry added 35000 new workers last year.
  • Patents: The industry’s strong position in research and development is highlighted by over, 4500 patents.
  • Grants: Moreover, the neurosurgery sector has secured more than 300 grants.
  • Global Search Growth: The industry experienced a yearly global search growth of 5.56%. This is an indication of rising interest and awareness.

A Snapshot of the Global Neurosurgery Industry

The neurosurgery market exhibits a diverse and evolving landscape, as indicated by the industry data. Despite a yearly contraction rate of -6.16%, over 200 startups actively contribute to innovation in this field. Among them, 70+ are early-stage ventures, and over 170 engage in mergers and acquisitions.

The strong patent activity characterizes the neurosurgery industry, with more than 4500 patents filed by over 1800 applicants. The yearly patent growth rate stands at 4.06%, emphasizing ongoing research and development efforts. The United States leads in patent issuance, with over 2000 patents, followed by China with more than 850.

Explore the Funding Landscape of the Neurosurgery Industry

Investment in the neurosurgery sector is substantial, averaging USD 18.8 million per funding round. Over 200 investors have participated in more than 650 closed funding rounds, supporting growth and innovation across 200 companies.

Who is Investing in Neurosurgery Solutions?

The neurosurgery industry benefits from financial support, with top investors contributing over USD 350 million. Below are the details of the top investors, their invested value, and the number of companies they have supported:

Here are the evolving neurosurgery trends changing the landscape along with the firmographic data:

  • Magnetic Resonance Imaging (MRI) provides detailed brain imaging for neurosurgical planning. Over 1600 companies employ more than 230K individuals in this field. Despite adding over 11K new employees last year, the annual trend growth rate stands at -3.91%.
  • Robotic Surgery is a rapidly growing sector within neurosurgery. It involves over 1300 companies and a workforce exceeding 265K employees. The industry added more than 11K new employees last year. The annual trend growth rate of 18.48% underscores the increasing adoption and advancements in robotic-assisted surgical procedures.
  • Surgical Navigation Systems enhance surgical accuracy and patient safety, driving their adoption in medical practices. This trend involves over 70 companies, employing more than 6K individuals. Further, there was an increase of over 3K new employees in this sector last year, with an annual trend growth rate of 16.79%.

5 Top Examples from 200+ Innovative Neurosurgery Startups

The five innovative startups showcased below are picked based on data including the trend they operate within and their relevance, founding year, funding status, and more. Book a demo to find promising startups, emerging trends, or industry data specific to your company’s needs and objectives.

Neurochase develops CED Drug Delivery System

UK-based startup Neurochase specializes in intraparenchymal drug delivery for precise treatment of neurological disorders. Its Neurochase Convection Enhanced Delivery (CED) system targets brain regions and ensures even distribution of therapeutic agents. It bypasses the blood-brain barrier and enables direct drug administration to affected areas. Further, the real-time monitoring feature within the CED system optimizes drug distribution and improves patient outcomes. Neurochase treats conditions such as glioblastoma, Parkinson’s disease, and epilepsy.

NeuroMind offers Clinical Decision Support Tools

Dutch startup NeuroMind develops a neurosurgical application that offers interactive clinical decision support for neurosurgeons and neurologists. It has over 120 classification systems and 30 rapid decision-making tools to aid professionals in making decisions across various specializations. After selecting the tool, an interactive decision tree guides through a series of choices leading to clinical decisions based on the inputs. NeuroMind empowers healthcare professionals by enhancing patient care and decision-making.

QAS.AI provides AI-based Neurovascular Treatments

US-based startup QAS.AI develops AI-driven software for real-time assistance during endovascular procedures, supporting surgical outcomes. The software detects areas of inadequate blood flow in the brain and predicts the efficacy of aneurysm correction six months after embolization. It acts as an interface between the c-arm position, image acquisition parameters, and angiographic parametric imaging processing, ensuring precise tissue perfusion assessment. After each angiogram, the software automatically places regions of interest, compares them to baselines, and detects ischemia locations with high probability. QAS.AI’s modules offer real-time feedback to surgeons enabling them to modify aneurysm treatment plans during procedures and integrate them into clinical workflows.

SurgeonsLab creates Surgical Simulations

Swiss startup SurgeonsLab builds SurgTrain, an autonomous neurosurgical simulator to enhance the skills of neurosurgeons. The simulator features a precise multimodal position sensing system that allows surgeons to train with authentic surgical instruments without the constraints of cables and peripherals. Throughout the simulation, SurgTrain automatically detects and enables the interchangeability of instruments such as micro scissors, dissectors, and forceps. SurgeonsLab’s technology is applicable in both pre-operative and intraoperative settings, promoting safe surgical outcomes.

PreOperative Performance optimizes Diffusion-weighted MRI

Canadian startup PreOperative Performance develops technology to create modules representative of white matter tissue, enhancing diffusion MR imaging accuracy. Its Phantom X product creates anisotropic diffusion modules with fully parameterized bifurcations and intersections. It supports imaging studies, interrogates diffusion dataset quality, and detects data errors. This ensures MR systems produce reliable datasets, free from error sources, for patient treatment planning. The approach improves neurosurgical patient quality of life, enhances clinical team performance, and reduces healthcare system costs. PreOperative Performance has applications in neuro-oncology, traumatic brain injury, degenerative diseases, and epilepsy

Gain Comprehensive Insights into Neurosurgery Trends, Startups, or Technologies

The neurosurgery market report highlights an industry positioned for advancements driven by innovations in robotic surgery, surgical navigation systems, and MRI technologies. Emerging trends suggest a move toward precision and minimally invasive procedures, supported by growing investments and patent activity. Get in touch to explore all 200+ startups and scaleups, as well as all industry trends impacting neurosurgery companies.

IR Outro CTA